US · Healthcare · Medical Devices
EPS came in at -0.53 against a street estimate of -0.52 — a miss of 1.9%.
Analysts rate CVRx Inc a buy (3 buy, 3 hold, 1 sell out of 7) with an average price target of $4.58.
| Fund | Stake |
|---|---|
| Johnson & Johnson | 15.11% |
| NEA Management Company, LLC | 7.34% |
| BlackRock Inc | 4.67% |
| Royal Bank of Canada | 4.63% |
| GSK PLC | 3.78% |
| Vanguard Capital Management, LLC | 3.42% |
| Silvercrest Asset Management Group LLC | 3.30% |
| Geode Capital Management, LLC | 1.65% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CVRx Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.